Immediate hypersensitivity to rifampicin in 3 patients: Diagnostic procedures and induction of clinical tolerance

International Archives of Allergy and Immunology

Volumn 140, Issue 1, 2006, Pages 20-26

  Buergin, Stephan ^a   Scherer, Kathrin ^a   Häusermann, Peter ^a   Bircher, Andreas J ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Desensitization; Drug hypersensitivity; Immediate hypersensitivity; Leukotriene stimulation test; Lymphocyte transformation test; Rifampicin; Skin tests; Urticaria

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIALLERGIC AGENT; ANTIBIOTIC AGENT; CD63 ANTIGEN; CEFAZOLIN; CETIRIZINE; CIPROFLOXACIN; CLEMASTINE FUMARATE; CORTICOSTEROID; ETHAMBUTOL; FLUCLOXACILLIN; FUSIDATE SODIUM; HYDROCORTISONE SODIUM SUCCINATE; ISONIAZID; LEVOFLOXACIN; PEPTIDOLEUKOTRIENE; RIFAMPICIN; RIFAMPICIN LACTAB; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AGED; ALLERGIC URTICARIA; ANTIBIOTIC THERAPY; ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; DESENSITIZATION; DIAGNOSTIC KIT; DIARRHEA; DRUG ERUPTION; DRUG EXPOSURE; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG REEXPOSURE; FEMALE; GASTROINTESTINAL CRAMP; GASTROINTESTINAL SYMPTOM; HUMAN; HYDROCEPHALUS; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOASSAY; IMMUNOLOGICAL TOLERANCE; INTRACUTANEOUS TEST; KNEE PROSTHESIS; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; MALE; MONARTHRITIS; MYCOBACTERIUM BOVIS; NAUSEA; OSTEOMYELITIS; PEPTIDOLEUKOTRIENE STIMULATION TEST; PRICK TEST; PRIORITY JOURNAL; PRURITUS; SERODIAGNOSIS; SHIVERING; SKIN TEST; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIC HEPATITIS; TUBERCULOUS MENINGITIS; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTITUBERCULAR; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; INJECTIONS, INTRAVENOUS; INTRADERMAL TESTS; LEPROSTATIC AGENTS; MALE; MIDDLE AGED; RIFAMPIN; URTICARIA;

EID: 33646006377     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091839     Document Type: Article

References (36)

1. Greenberger P: Desensitization and test-dosing for the drug-allergic patient. Ann Allergy Asthma Immunol 2000;85:250-251.
2. Beall G, Sanwo M, Hussain H: Drug reactions and desensitization in AIDS. Immunol Allergy Clin North Am 1997;17:319-338.
3. Greenberger PA: Drug challenge and desensitization protocols. Immunol Allergy Clin North Am 1998;18:759-772.
4. Naclerio R, Mizrahi EA, Adkinson NF: Immunologic observations during desensitization and maintenance of clinical tolerance to penicillins. J Allergy Clin Immunol 1983;71:294-301.
5. Bircher AJ: Desensibilisierung bei Überempfindlichkeitsreaktionen auf Arzneimittel. Allergologie 1997;20:412-422.
6. Kim JH, Kim HB, Kim BS: Rapid oral desensitization to isoniazid, rifampicin and ethambutol. Allergy 2003;58:540-541.
7. Acocella G: Pharmacokinetics and metabolism of rifampin in humans. Rev Infect Dis 1983;5:S428-S432.
8. Widmer AF, Gaechter A, Ochsner PE, Zimmerli W: Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992;14:1251-1253.
9. Bircher AJ, Figueiredo V, Scherer K, Surber C: Accuracy of serial dilution concentrations for intradermal skin testing: a neglectable problem? Contact Dermatitis 2004;50:186-187.
10. Manfredi M, Severino M, Testi S, Macchia D, Ermini G, Pichler WJ, Campi P: Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004;113:155-160.
11. Schaub N, Bircher AJ: Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy 2000;55:191-193.
12. Sanz ML, Maselli JP, Gamboa PM, Oehling A, Dieguez I, de Week AL: Flow cytometric basophil activation test: a review. J Investig Allergol Clin Immunol 2002;12:143-154.
13. Bircher AJ, Scherer K, Grize L, Schindler C: Non-irritant threshold concentrations for intradermal skin tests with rifampicin, ciprofloxacin, and clarithromycin. Allergy Clin Immunol Int 2005;suppl 1:57.
14. Abong JM, Andutan MMC: Antituberculous drug desensitization. J Allergy Clin Immunol 1999;103:S34.
15. Alonso MD, De La Hoz B, Cuevas M, Beick A: Desensibilización a rifampicina. A propósito de un caso. Med Clin 1996;106:319.
16. Holland CL, Malasky C, Ogunkoya A, Bielory L: Rapid oral desensitization to isoniazid and rifampin. Chest 1990;98:1518-1519.
17. Matz J, Borish LC, Routes JM, Rosenwasser LJ: Oral desensitization to rifampin and ethambutol in mycobacterial disease. Am J Respir Crit Care Med 1994;149:815-817.
18. Pech O, May A, Henrich R, Mayer G: Schnelldesensibilisierung mit Rifampicin. Dtsch Med Wochenschr 2001;126:16.
19. Parra FM, Pérez Elias MJ, Cuevas M, Ferreira A: Serum sickness-like illness associated with rifampicin. Ann Allergy 1994;73:123-125.
20. Trautmann A, Bröcker EB, Klein CE: Hautreaktionen bei antituberkulöser Chemotherapie. Allergologie 1995;18:138-144.
21. Girling DJ, Hitze KL: Adverse reactions to rifampicin. Bull World Health Organ 1979;57:45-49.
22. O'Mahony MG, Kar CW: Relationship between rifampicin-dependent antibody scores, serum rifampicin concentrations and symptoms in patients with adverse reactions to intermittent rifampicin treatment. Clin Allergy 1973;3:353-362.
23. Ohta K, Labovitz E, Harbeck RJ, Takizawa H, Ishii A, Miyamoto T: Development of RAST for detecting anti-rifampicin IgE antibodies. J Allergy Clin Immunol 1987;79:221.
24. Grosset J, Leventis S: Adverse effects of rifampin. Rev Infect Dis 1983;5(suppl 3):S440-S450.
25. Holdiness MR: Adverse cutaneous reactions to antituberculosis drugs. Int J Dermatol 1985;24:280-285.
26. Aquinas M, Allan WG, Horsfall PA, Jenkins PK, Hung-Yan W, Girling D, et al: Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Br Med J 1972;i:765-771.
27. Canova CR, Kuhn M, Zellweger U, Reinhardt WH: Fulminante, rasch reversible Hepatitis und lebensgefährliche Anaphylaxie nach Rifampicin bei einer HIV-positiven Patientin mit latenter Nebennierenrinden-Insuffizienz. Schweiz Med Wochenschr 1996;126:392-397.
28. Cnudde F, Leynadier F: The diagnosis of allergy to rifampicin confirmed by skin test. Am J Med 1994;97:403-404.
29. Harland RW, Lindblom SS, Munnell MO: Anaphylaxis from rifampin. Am J Med 1992;92:581-582.
30. Leynadier F, Dehee D, Mellin B, Dry J: Le choc anaphylactique à la rifampicin. Entité rare mais grave. Paris, Entretiens de Bichat Pitié-Salpétrière Médecine, 1988.
31. Alvarez Cuesta E, Hernández-Peña J, Blanco R, Gozalo F, Cuesta J: Oral desensitization with antituberculosis drugs. J Allergy Clin Immunol 1997;99:S431.
32. Driria I, Souissi R, Dakhlaoui R, Jequirim MS, Chebbi ML: Désensibilisation orale aux antituberculeux. Rev Pneumol Clin 1997;53:104-106.
33. Dutau H, Saadjian M, Bonneau V, Charpin D: Unsuccessful rapid intravenous desensitization to rifampicin. Allergy 2000;55:778-779.
34. Solensky R: Drug desensitization (review). Immunol Allergy Clin North Am 2004;24:425-443.
35. Borish L, Tamir R, Rosenwasser LJ: Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987;80:314-319.
36. Sullivan TJ: Antigen-specific desensitization of patients allergic to penicillins. J Allergy Clin Immunol 1982;69:500-508.